{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:16:32Z","timestamp":1793654192014,"version":"4.5.1"},"reference-count":206,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jhep.2016.02.021","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T19:30:51Z","timestamp":1460489451000},"page":"S84-S101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":914,"special_numbering":"S","title":["Mechanisms of HBV-induced hepatocellular carcinoma"],"prefix":"10.1016","volume":"64","author":[{"given":"Massimo","family":"Levrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.02.021_b0005","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Venook","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jhep.2016.02.021_b0015","unstructured":"Cancer IARC. Globocan. Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization; 2012. 9, http:\/\/globocan iarc fr\/Pages\/fact_sheets_cancer aspx."},{"key":"10.1016\/j.jhep.2016.02.021_b0020","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","article-title":"Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer","volume":"30","author":"McGivern","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","article-title":"Targeted therapies for hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0033-1345721","article-title":"Molecular mechanisms of HBV-associated hepatocarcinogenesis","volume":"33","author":"Guerrieri","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.02.021_b0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jhep.2013.08.019","article-title":"Genetics of hepatocellular carcinoma: the next generation","volume":"60","author":"Nault","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0040","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhep.2004.10.026","article-title":"Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance","volume":"42","author":"Ahn","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2016.02.021_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2003.10.048","article-title":"Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection","volume":"126","author":"Pollicino","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0065","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0070","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.3949\/ccjm.76.s3.02","article-title":"Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment","volume":"76","author":"Sherman","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jhep.2016.02.021_b0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2011.12.045","article-title":"Estrogen receptor a represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4a","volume":"142","author":"Wang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.02.021_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2016.02.021_b0090","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1053\/jhep.2002.36366","article-title":"Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China","volume":"36","author":"Ming","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2012.09.005","article-title":"Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma","volume":"58","author":"Pollicino","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0100","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.02.021_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jhep.2016.02.021_b0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0120","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0125","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/JVI.02574-12","article-title":"Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription","volume":"87","author":"Benhenda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/scisignal.2001906","article-title":"Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription","volume":"5","author":"Cougot","year":"2012","journal-title":"Sci Signal"},{"key":"10.1016\/j.jhep.2016.02.021_b0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL clinical practice guidelines: management of CHB","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jvh.12380","article-title":"Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection","volume":"22","author":"Tu","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.02.021_b0150","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1002\/hep.22962","article-title":"Hepatitis B and hepatocellular carcinoma","volume":"49","author":"Di Bisceglie","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0155","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0160","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0165","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.0308232100","article-title":"Specific mutations of hepatitis B virus in plasma predict liver cancer development","volume":"101","author":"Kuang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications","volume":"61","author":"Pollicino","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0175","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jnci\/djp180","article-title":"Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis","volume":"101","author":"Liu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2016.02.021_b0180","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","article-title":"Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients","volume":"133","author":"Chen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0185","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.1840360605","article-title":"Revisiting the cytopathic effect of hepatitis B virus infection","volume":"36","author":"Bruss","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0190","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/jvi.60.3.880-887.1986","article-title":"Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice","volume":"60","author":"Chisari","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0195","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice","volume":"59","author":"Chisari","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.02.021_b0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","article-title":"Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis","volume":"97","author":"Wang","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jhep.2016.02.021_b0205","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","article-title":"Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage","volume":"25","author":"Hsieh","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2016.02.021_b0210","doi-asserted-by":"crossref","first-page":"46384","DOI":"10.1074\/jbc.M403568200","article-title":"Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase","volume":"279","author":"Hung","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.02.021_b0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/carcin\/bgr296","article-title":"Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis","volume":"33","author":"Wang","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2016.02.021_b0220","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.humpath.2013.01.020","article-title":"Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B","volume":"44","author":"Mathai","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2016.02.021_b0225","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/135965350801300701","article-title":"The oncogenic potential of hepatitis B virus rtA181T\/ surface truncation mutant","volume":"13","author":"Lai","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2016.02.021_b0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/135965350901400216","article-title":"Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy","volume":"14","author":"Lai","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2016.02.021_b0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jhep.2011.06.028","article-title":"Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases","volume":"56","author":"Lee","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3851\/IMP1552","article-title":"Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy","volume":"15","author":"Yeh","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2016.02.021_b0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172\u2217 mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0250","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1471-2407-11-398","article-title":"Emergence of the rtA181T\/sW172\u2217 mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B","volume":"21","author":"Yeh","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhep.2016.02.021_b0255","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.2483","article-title":"Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma","volume":"45","author":"Jiang","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0260","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/hep.23943","article-title":"Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma","volume":"52","author":"Clifford","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028798","article-title":"Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection","volume":"6","author":"Chan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.02.021_b0270","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ng.638","article-title":"Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"42","author":"Zhang","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humimm.2009.09.353","article-title":"149G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population","volume":"71","author":"Gu","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2016.02.021_b0280","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2004.11.026","article-title":"Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection\u2013association between TGF-beta1 polymorphisms and hepatocellular carcinoma","volume":"42","author":"Migita","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0285","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.annepidem.2008.03.003","article-title":"The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China","volume":"18","author":"Long","year":"2008","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jhep.2016.02.021_b0290","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/carcin\/bgn090","article-title":"MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"29","author":"Yoon","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhep.2016.02.021_b0295","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.21735","article-title":"Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma","volume":"46","author":"Yuan","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0300","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.03.026","article-title":"Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis","volume":"53","author":"Wang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0305","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Transancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0310","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinoma identifies new mutations signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0315","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copynumber changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0320","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0325","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Cleary","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0330","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.27198","article-title":"Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification","volume":"60","author":"Ahn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0335","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3218","article-title":"High frequence of telomerase reverse-transcriptase promoter somatic mutations in hepatocellularcarcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.02.021_b0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0350","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1038\/sj.onc.1206492","article-title":"Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene","volume":"22","author":"Paterlini-Br\u00e9chot","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0355","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11262-009-0441-3","article-title":"Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase","volume":"40","author":"Liu","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.jhep.2016.02.021_b0360","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/gut.2008.174029","article-title":"Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT","volume":"58","author":"Luan","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0365","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent inmouse and human hepatocellular carcinomas","volume":"95","author":"de Coste","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/73448","article-title":"AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1","volume":"24","author":"Satoh","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0380","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/gutjnl-2013-306228","article-title":"Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas","volume":"64","author":"Amaddeo","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0385","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.02.021_b0395","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0400","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0405","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2011.01.040","article-title":"Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening","volume":"19","author":"Sawey","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2016.02.021_b0410","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.26402","article-title":"Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0415","first-page":"564","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0425","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Li","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0430","first-page":"1","article-title":"RNAi screening identifies a mechanism of sorafenib resistance in liver cancer","author":"Rudalska","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.02.021_b0435","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1158\/0008-5472.CAN-08-0742","article-title":"Focal gains of VEGFA and molecular classification of hepatocellular carcinoma","volume":"68","author":"Chiang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0440","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0030-1247131","article-title":"Molecular classification and novel targets in hepatocellular carcinoma: recent advancements","volume":"30","author":"Hoshida","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.02.021_b0445","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nm1377","article-title":"A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells","volume":"12","author":"Lee","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.02.021_b0450","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-07-6013","article-title":"EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma","volume":"68","author":"Yamashita","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0455","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2011.02.006","article-title":"Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0460","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0465","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","article-title":"Pivotal role of mTOR signaling in hepatocellular carcinoma","volume":"135","author":"Villanueva","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0470","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI27236","article-title":"Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype","volume":"116","author":"Kaposi-Novak","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0475","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/hep.22283","article-title":"Transforming growth factor-b gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer","volume":"47","author":"Coulouarn","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0480","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2010.01.015","article-title":"IGF activation in a molecular subclass of hepatocellular carcinoma and preclinical efficacy of IGF-1R blockage","volume":"52","author":"Tovar","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0485","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2009.03.028","article-title":"Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo","volume":"51","author":"Newell","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0490","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/j.gastro.2012.09.002","article-title":"Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice","volume":"143","author":"Villanueva","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0495","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI66024","article-title":"Cancer stem cells in the development of liver cancer","volume":"123","author":"Yamashita","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0500","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stemlike phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2016.02.021_b0505","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-09-2823","article-title":"Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma","volume":"70","author":"Woo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0510","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0515","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.27732","article-title":"DNA Methylation-based prognosis and epidrivers in hepatocellular carcinoma","volume":"61","author":"Villanueva","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0520","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1053\/j.gastro.2011.02.009","article-title":"MicroRNAbased classification of hepatocellular carcinoma and oncogenic role of miR-517a","volume":"140","author":"Toffanin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0525","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.20375","article-title":"Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0530","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-11-2322","article-title":"Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib","volume":"18","author":"Lachenmayer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0535","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26004","article-title":"Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR","volume":"57","author":"Keng","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0540","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0030-1247134","article-title":"Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma","volume":"30","author":"Imbeaud","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.02.021_b0545","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmed.2015.00036","article-title":"Non-coding RNAs in primary liver cancer","volume":"2","author":"Ghidini","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.jhep.2016.02.021_b0550","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2015.07.025","article-title":"The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma","volume":"2","author":"Moyo","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0555","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.22749","article-title":"Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"Ura","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/hep.23008","article-title":"Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression","volume":"50","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2009.12.043","article-title":"Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3","volume":"53","author":"Wang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0570","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.23660","article-title":"Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0575","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","article-title":"MicroRNA expression, survival, and response to interferon in liver cancer","volume":"361","author":"Ji","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.02.021_b0580","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.26941","article-title":"MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0585","article-title":"Long Non-coding RNA DILC Represses Self-renewal of Liver Cancer Stem Cells via Inhibiting Autocrine IL-6\/STAT[3] Axis","author":"Wang","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0590","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0595","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep.23247","article-title":"Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma","volume":"51","author":"Zhao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014460","article-title":"Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.02.021_b0605","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jhep.2012.01.009","article-title":"Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib","volume":"56","author":"Lachenmayer","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"Simon","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0615","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/labinvest.2008.52","article-title":"The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma","volume":"88","author":"Sasaki","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0620","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gut.2010.231993","article-title":"EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies","volume":"60","author":"Cai","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0625","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhep.2015.08.031","article-title":"Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications","volume":"64","author":"Sciarra","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0630","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.21668","article-title":"Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through downregulation of stathmin","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0635","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0640","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-10-3342","article-title":"EZH2-mediated concordant repression of Wnt antagonists promotes \u03b2-catenin dependent hepato-carcinogenesis","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2010.11.014","article-title":"Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges","volume":"305","author":"Bouchard","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2016.02.021_b0650","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.90.1.89","article-title":"A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro","volume":"90","author":"Garcia","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0655","first-page":"1653","article-title":"Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma","volume":"7","author":"Wang","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0660","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","article-title":"Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers","volume":"22","author":"Ferber","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0665","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1038\/sj.onc.1204835","article-title":"Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging","volume":"20","author":"Gozuacik","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0670","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/gut.2004.054452","article-title":"Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas","volume":"54","author":"Murakami","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0675","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/liv.12807","article-title":"Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma","volume":"35","author":"Saitta","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.02.021_b0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003065","article-title":"Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach","volume":"8","author":"Ding","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jhep.2016.02.021_b0685","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Lau","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2016.02.021_b0690","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122","volume":"64","author":"Liang","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0695","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/gutjnl-2014-308482","article-title":"Authors\u2019 response: virus-host interactions in HBV-related hepatocellular carcinoma: more to be revealed?","volume":"64","author":"Cao","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2016.02.021_b0700","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1096\/fj.11-187781","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2016.02.021_b0705","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0710","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0715","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0720","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/jhep.2000.7298","article-title":"Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error","volume":"31","author":"Kawai","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0725","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1073\/pnas.93.14.7300","article-title":"Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal","volume":"93","author":"Aoki","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0730","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/MCB.23.15.5282-5292.2003","article-title":"Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles","volume":"23","author":"Forgues","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2016.02.021_b0735","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.onc.1200850","article-title":"The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice","volume":"14","author":"Terradillos","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0740","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004343","article-title":"The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B Virus and herpes simplex virus type 1","volume":"10","author":"Ducroux","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2016.02.021_b0750","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0755","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cellsig.2012.10.013","article-title":"MiR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A","volume":"25","author":"Wei","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.jhep.2016.02.021_b0760","article-title":"Genome-wide identification of direct HBx targets that control HBV replication","author":"Guerrieri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0765","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0770","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0775","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1073\/pnas.0911373107","article-title":"The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication","volume":"107","author":"Sir","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0780","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2012.01.021","article-title":"Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication","volume":"426","author":"Hodgson","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.02.021_b0785","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.06442-11","article-title":"The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0790","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M606774200","article-title":"The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription","volume":"282","author":"Cougot","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.02.021_b0795","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.25781","article-title":"Subset of Suz12\/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein","volume":"56","author":"Studach","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0800","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-2928","article-title":"PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during hepatitis B virus-induced liver carcinogenesis","author":"Zhang","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0805","article-title":"Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2","author":"Fan","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0810","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1053\/j.gastro.2007.01.034","article-title":"Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein","volume":"132","author":"Park","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0815","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2008.10.019","article-title":"Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A","volume":"50","author":"Zheng","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0820","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.21552","article-title":"Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis","volume":"45","author":"Plentz","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0825","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1096\/fj.01-0977com","article-title":"Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis","volume":"16","author":"Wiemann","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2016.02.021_b0830","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10599","article-title":"Senescence surveillance of premalignant hepatocytes limits liver cancer development","volume":"479","author":"Kang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0835","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/gast.1997.v112.pm9024303","article-title":"Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease","volume":"112","author":"Kojima","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0840","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"Nault","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0845","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2008.10.048","article-title":"Senescence and Immortality in Hepatocellular Carcinoma","volume":"286","author":"Ozturk","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2016.02.021_b0850","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1073\/pnas.91.6.2230","article-title":"Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0855","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1099\/vir.0.029512-0","article-title":"Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by down-regulating levels of p16 and p21 via DNA methylation","volume":"92","author":"Park","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0860","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1128\/JVI.02627-10","article-title":"Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment","volume":"85","author":"Li","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0865","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00154-08","article-title":"Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential","volume":"82","author":"Clippinger","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0870","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/BJ20102071","article-title":"Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4","volume":"435","author":"Cho","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2016.02.021_b0875","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1099\/vir.0.83214-0","article-title":"The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor \u03b1-mediated apoptosis by activation of phosphoinositol 3-kinase and \u03b2-catenin","volume":"88","author":"Pan","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2016.02.021_b0880","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/j.gastro.2006.12.030","article-title":"Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis","volume":"132","author":"Pang","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0885","doi-asserted-by":"crossref","first-page":"39076","DOI":"10.1074\/jbc.M305101200","article-title":"Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1\u03b1 through activation of mitogen activated protein kinase pathway","volume":"278","author":"Yoo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.02.021_b0890","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2006.051246","article-title":"Hepatitis B virus core proteins shift TGF-\u03b2 responses from tumor suppression to promotes angiopoietin-2 expression in liver tissue. Role of HBV X protein","volume":"169","author":"Sanz-Camern","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2016.02.021_b0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004355","article-title":"Liver cancer-derived hepatitis C virus epithelial-mesenchymal transition","volume":"4","author":"Battaglia","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2016.02.021_b0900","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","article-title":"HCV core-mediated activation of latent TGF-\u03b2 via thrombospondin drives the cross-talk between hepatocytes and stromal environment","volume":"59","author":"Benzoubir","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0905","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI118427","article-title":"Regulation of transforming growth factor-\u03b2 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis","volume":"97","author":"Yoo","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2016.02.021_b0910","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.856201","article-title":"The hepatitis B virus encoded oncoprotein pX amplifies TGF-\u03b2 family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis","volume":"15","author":"Lee","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2016.02.021_b0915","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/onc.2011.255","article-title":"Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer","volume":"31","author":"Arzumanyan","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b0920","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1158\/0008-5472.CAN-10-3951","article-title":"Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?","volume":"71","author":"Arzumanyan","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0925","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1158\/0008-5472.CAN-07-0908","article-title":"Activation of hepatic stem cell marker EpCAM by Wnt-\u03b2-catenin signaling in hepatocellular carcinoma","volume":"67","author":"Yamashita","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0930","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.02.021_b0935","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","article-title":"Identification of microRNA-181 by genome wide screening as a critical player in EpCAM-positive hepatic cancer stem cells","volume":"50","author":"Ji","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0940","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2007.15.5945","article-title":"Liver cancer stem cells","volume":"26","author":"Sell","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2016.02.021_b0945","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(03)00217-4","article-title":"Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection","volume":"39","author":"Iavarone","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.02.021_b0950","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx gene of hepatitis B virus induces liver cancer in transgenic mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b0955","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-07-5082","article-title":"COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis","volume":"14","author":"Ma","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0960","doi-asserted-by":"crossref","unstructured":"Belloni L, li L, Palumbo GA et al. HAPs hepatitis B virus (HBV) capsid inhibitors block core protein interaction with the viral minichromosome and host cell genes and affect cccDNA transcription and stability. AASLD 2013 Hepatology 58, S1, 138 10.","DOI":"10.1016\/S0168-8278(13)60373-6"},{"key":"10.1016\/j.jhep.2016.02.021_b0965","doi-asserted-by":"crossref","unstructured":"Gruffaz M, Testoni B, Durantel D et al. Hepatitis B core (HBc) protein is a key and very early negative regulator of the interferon response. AASLD 2013 Hepatology, 58, S1, 136 56.","DOI":"10.1016\/S0168-8278(13)60380-3"},{"key":"10.1016\/j.jhep.2016.02.021_b0970","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/1471-2164-13-563","article-title":"Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions","volume":"13","author":"Guo","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jhep.2016.02.021_b0975","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.20615","article-title":"Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes","volume":"41","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0980","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.22889","article-title":"Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis","volume":"49","author":"Yang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.02.021_b0985","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/1541-7786.MCR-07-0098","article-title":"Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1","volume":"5","author":"Hsieh","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhep.2016.02.021_b0990","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.87.8.2970","article-title":"A trans-activator function is generated by integration of hepatitis B virus preS\/S sequences in human hepatocellular carcinoma DNA","volume":"87","author":"Caselmann","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.02.021_b0995","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/viro.1996.0594","article-title":"The hepatitis B virus large surface protein (LHBs) is a transcriptional activator","volume":"225","author":"Hildt","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2016.02.021_b1000","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1038\/343457a0","article-title":"The preS2\/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator","volume":"343","author":"Kekule","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.02.021_b1005","first-page":"3335","article-title":"Integrated hepatitis B virus X and 30 truncated preS\/S sequences derived from human hepatomas encode functionally active transactivators","volume":"9","author":"Schluter","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.02.021_b1010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2893.1999.00154.x","article-title":"Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues","volume":"6","author":"Zhong","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2016.02.021_b1015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/emboj\/21.4.525","article-title":"The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1\/Erk2 signaling in transgenic mice","volume":"21","author":"Hildt","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2016.02.021_b1020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.02.021_b1025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","article-title":"Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling","volume":"155","author":"He","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.02.021_b1030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2015.07.026","article-title":"Cell. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer","volume":"162","author":"Font-Burgada","year":"2015","journal-title":"Cell"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816001525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816001525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T12:20:21Z","timestamp":1655641221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816001525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":206,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0168827816001525"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of HBV-induced hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}